P. Hales

A. Gomez-Muñoz, A. Martín, D. Brindley, 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR: LA‐corpulent rats treated with d‐fenfluramine

J. Russell, D. Brindley, P. Hales, 1992, British journal of pharmacology.

Optimization of a series of dipeptides with a P3 β-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome

M. Sintchak, L. Dick, J. Blank, 2012 .

Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome.

Jonathan L Blank, Christopher Tsu, Christopher Blackburn, 2010, Bioorganic & medicinal chemistry letters.

Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

T. Parsons, James M. Gavin, L. Dick, 2002, The Journal of Biological Chemistry.

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins.

C. Berul, H. Wakimoto, M. Donoghue, 2003, Journal of molecular and cellular cardiology.

Effects of the lipase inhibitors, Triton WR‐1339 and tetrahydrolipstatin on the synthesis and secretion of lipids by rat hepatocytes

D. Brindley, P. Hales, D. Hermier, 1991, FEBS letters.

A rapid assay for measuring the activity and the Mg2+ and Ca2+ requirements of phosphatidate phosphohydrolase in cytosolic and microsomal fractions of rat liver.

D. Brindley, P. Hales, A. Martin, 1987, The Biochemical journal.

Rapid activation of glycogen phosphorylase by steroid hormones in cultured rat hepatocytes.

A. Gomez-Muñoz, D. Brindley, P. Hales, 1989, The Biochemical journal.

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

A. Berger, J. Bolen, O. Tayber, 2011, Clinical Cancer Research.

KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism

S. Tirrell, A. Berger, J. Garnsey, 2015, PloS one.

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

T. Soucy, E. Olhava, M. Sintchak, 2010, The Biochemical journal.

Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome

E. Winzeler, L. Tilley, L. Dick, 2018, Journal of medicinal chemistry.

Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome

E. Winzeler, L. Tilley, D. Fidock, 2021, Proceedings of the National Academy of Sciences.

Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea

A. Berger, Jie Yu, L. Dick, 2011, Cancer Chemotherapy and Pharmacology.

Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome

M. Bogyo, L. Dick, C. Blackburn, 2014, Journal of the American Chemical Society.